China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through the country's public hospitals, saying an investigation into quality ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-02-09 05:35:00